These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 35033953

  • 1. Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemic.
    Dadiomov D, Trotzky-Sirr R, Shooshtari A, Qato DM.
    Drug Alcohol Depend; 2022 Mar 01; 232():109291. PubMed ID: 35033953
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report.
    Flavin L, Tofighi B, Krawczyk N, Schatz D, McNeely J, Butner J.
    J Addict Med; 2022 Mar 01; 16(1):e59-e61. PubMed ID: 35120069
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails.
    Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, Pollack HA, Schneider JA.
    JAMA Netw Open; 2024 Sep 03; 7(9):e2434704. PubMed ID: 39316401
    [Abstract] [Full Text] [Related]

  • 8. An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.
    Brezel ER, Powell T, Fox AD.
    Subst Abus; 2020 Sep 03; 41(2):150-154. PubMed ID: 31800376
    [Abstract] [Full Text] [Related]

  • 9. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.
    Sufrin C, Kramer CT, Terplan M, Fiscella K, Olson S, Voegtline K, Latkin C.
    JAMA Netw Open; 2022 Jan 04; 5(1):e2144369. PubMed ID: 35050354
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. United States county jail treatment and care of pregnant incarcerated persons with opioid use disorder.
    Benck KN, Seide K, Jones AK, Omori M, Rubinstein LB, Beckwith C, Nowotny KM.
    Drug Alcohol Depend; 2023 Jun 01; 247():109863. PubMed ID: 37071946
    [Abstract] [Full Text] [Related]

  • 12. "And Then COVID Hits": A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19.
    Harrington C, Bailey A, Delorme E, Hano S, Evans EA.
    Subst Use Misuse; 2023 Jun 01; 58(2):266-274. PubMed ID: 36510800
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
    Currie JM, Schnell MK, Schwandt H, Zhang J.
    JAMA Netw Open; 2021 Apr 01; 4(4):e216147. PubMed ID: 33856474
    [Abstract] [Full Text] [Related]

  • 15. Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters.
    Bandara S, Kennedy-Hendricks A, Merritt S, Barry CL, Saloner B.
    Addiction; 2021 Dec 01; 116(12):3473-3481. PubMed ID: 33999458
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons.
    Bandara S, Kennedy-Hendricks A, Merritt S, Barry CL, Saloner B.
    J Addict Med; 2020 Dec 01; 14(5):e257-e260. PubMed ID: 32868681
    [Abstract] [Full Text] [Related]

  • 19. Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative.
    Krawczyk N, Bandara S, Merritt S, Shah H, Duncan A, McEntee B, Schiff M, Ahmad NJ, Whaley S, Latimore A, Saloner B.
    Addict Sci Clin Pract; 2022 Jun 02; 17(1):30. PubMed ID: 35655293
    [Abstract] [Full Text] [Related]

  • 20. Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting.
    Berk J, Del Pozo B, Rich JD, Lee JD.
    J Addict Med; 2022 Jun 02; 16(4):396-398. PubMed ID: 34954747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.